The role of GPLD1 in chronic diseases.

Jing Cao, Anni Zhou, Zhuoyang Zhou, Hui Liu, Shaohui Jia

Journal: Journal of cellular physiology 2023;238(7):1407-1415

PMID: 37393554

Abstract

Glycosylphosphatidylinositol-specific phospholipase D (GPLD1) is a specific enzyme for glycosylphosphatidylinositol (GPI) anchors, thereby exerting its biological functions by cleaving membrane-associated GPI molecules. GPLD1 is abundant in serum, with a concentration of approximately 5-10 µg/mL. Previous studies have demonstrated that GPLD1 plays a crucial role in the pathogenesis of numerous chronic diseases including disorders of lipid and glucose metabolism, cancer, and neurological disorders. In the present study, we reviewed the structure, functions, and localization of GPLD1 in chronic diseases, as well as exercise-mediated regulation of GPLD1, thus providing a theoretical support to develop GPLD1 as a new therapeutic target for chronic diseases.

Address: Graduate School of Wuhan Sports University, Wuhan, China.; School of Physical Education, Jinan University, Jinan, China.; Hubei Key Laboratory of Sport Training and Monitoring, Tianjiu Research and Development Center for Exercise Nutrition and Foods, College of Health Science, Wuhan Sports University, Wuhan, China.

DOI: 10.1002/jcp.31041